Your Article Summary
See Latest ArticlesEfficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: A meta-analysis of randomized clinical trials
Clinical Therapeutics, 06/19/09
Machado M et al. - Clodronate, pamidronate, and zoled-ronate were associated with reductions in morbidity in cancer patients with MBD with regard to preventing SREs, but were not associated with a reduction in overall mortality.
Related Articles
Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism
Osteoporosis International, 10/30/09
Relevance Score: 77%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
The effect of cessation of raloxifene treatment on bone turnover in postmenopausal women
Bone , 12/01/09
Spinal tuberculosis in post-liver transplantation patients: case reports
Transplant Infectious Disease, 11/30/09
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/25/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
The Use of Radiofrequency Ablation in the Treatment of Musculoskeletal Tumors
Journal of the American Academy of Orthopedic Surgeons, 12/01/09
Late recurrent hemarthrosis following knee arthroplasty associated with epithelioid angiosarcoma of bone
The Knee, 12/01/09
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/25/09